Current treatment strategies and future possibilities for sarcopenia in cirrhosis
J Hepatol
.
2023 May;78(5):889-892.
doi: 10.1016/j.jhep.2023.01.031.
Epub 2023 Feb 11.
Authors
Maryam Ebadi
1
,
Patrizia Burra
2
,
Alberto Zanetto
2
,
Aldo J Montano-Loza
3
Affiliations
1
Division of Gastroenterology & Liver Unit, University of Alberta Hospital, Edmonton, Alberta, Canada.
2
Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy.
3
Division of Gastroenterology & Liver Unit, University of Alberta Hospital, Edmonton, Alberta, Canada. Electronic address: montanol@ualberta.ca.
PMID:
36774981
DOI:
10.1016/j.jhep.2023.01.031
No abstract available
Keywords:
end-stage liver disease; low muscle mass; therapeutic strategies.
Publication types
Editorial
MeSH terms
Fibrosis
Humans
Liver Cirrhosis / pathology
Muscle, Skeletal / pathology
Sarcopenia* / etiology
Sarcopenia* / therapy